Active — Not RecruitingNot Applicable

Efficacy of IORT With CT-Guided HDR Brachytherapy for Treatment of Breast Cancer

United States358 participantsStarted 2015-03

Plain-language summary

The purpose of this study is to evaluate an investigational way to provide radiation therapy to treat early-stage breast cancer at the time of surgery.

Who can participate

Age range45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patient has elected breast conserving surgery or whole breast irradiation treatment for early-stage breast cancer.
✓. Tumor size must be less than or equal to 3 cm.
✓. Patient is 45 years of age or older.

Exclusion criteria

✕. Male patients.
✕. Pregnant patients.
✕. Breast cancer that involves the skin or chest wall.
✕. History of ipsilateral breast cancer.
✕. Multicentric breast cancer in the ipsilateral breast.
✕. Known BRCA gene mutation.
✕. Patient with nodal disease.
✕. Patient is undergoing initial medical treatment (hormone or chemotherapy) to reduce tumor size.

What they're measuring

Rate of Local Breast Tumor Recurrence

Timeframe: Up to 60 Months After Treatment

Trial details

NCT IDNCT02400658

SponsorShayna Showalter, MD

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-09

View on ClinicalTrials.gov More Breast Cancer trials